CD3-specific antibodies: a portal to the treatment of autoimmunity
CD3-specific antibodies: a portal to the treatment of autoimmunity
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Key Points
This Review summarizes the results from preclinical and clinical studies that use CD3-specific monoclonal antibody therapy and highlights future combination opportunities to enhance the efficacy of this promising immunotherapeutic.
CD3-specific monoclonal antibodies inactivate pathogenic cells by inducing rapid internalization of t...
Alternative Titles
Full title
CD3-specific antibodies: a portal to the treatment of autoimmunity
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_70755384
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_70755384
Other Identifiers
ISSN
1474-1733
E-ISSN
1474-1741,1365-2567
DOI
10.1038/nri2134